Recombinant Human INTS5 protein (GST tag N-Terminus)
Be the first to review this product! Submit a review
|
(0 Publication)
Recombinant Human INTS5 protein (GST tag N-Terminus) is a Human Full Length protein, in the 1 to 1019 aa range, expressed in Wheat germ, suitable for ELISA, WB.
View Alternative Names
KIAA1698, INTS5, Integrator complex subunit 5, Int5
- SDS-PAGE
Unknown
SDS-PAGE - Recombinant Human INTS5 protein (GST tag N-Terminus) (AB164292)
ab164292 on a 12.5% SDS-PAGE stained with Coomassie Blue.
Reactivity data
Sequence info
Properties and storage information
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
INTS5 is a component of the Integrator complex which is made up of several other subunits. This complex is responsible for the 3'-end processing of snRNA an important step in RNA maturation. By participating in these actions INTS5 and the Integrator complex contribute to the regulation of gene expression. Through these roles INTS5 helps maintain the proper function and stability of messenger RNA (mRNA) synthesis and processing.
Pathways
INTS5 plays an integral part in the RNA polymerase II transcription termination pathway. In this context the Integrator complex including INTS5 associates with the C-terminal domain of the RNA polymerase II enzyme. This association facilitates the proper termination and processing of snRNA transcripts. The complex frequently interacts with other proteins such as the Mediator complex emphasizing its role in fine-tuning RNA transcription processes.
Specifications
Form
Liquid
General info
Function
Component of the integrator complex, a multiprotein complex that terminates RNA polymerase II (Pol II) transcription in the promoter-proximal region of genes (PubMed : 33243860, PubMed : 38570683). The integrator complex provides a quality checkpoint during transcription elongation by driving premature transcription termination of transcripts that are unfavorably configured for transcriptional elongation : the complex terminates transcription by (1) catalyzing dephosphorylation of the C-terminal domain (CTD) of Pol II subunit POLR2A/RPB1 and SUPT5H/SPT5, (2) degrading the exiting nascent RNA transcript via endonuclease activity and (3) promoting the release of Pol II from bound DNA (PubMed : 33243860, PubMed : 38570683). The integrator complex is also involved in terminating the synthesis of non-coding Pol II transcripts, such as enhancer RNAs (eRNAs), small nuclear RNAs (snRNAs), telomerase RNAs and long non-coding RNAs (lncRNAs) (PubMed : 16239144). Mediates recruitment of cytoplasmic dynein to the nuclear envelope, probably as component of the integrator complex (PubMed : 23904267).
Sequence similarities
Belongs to the Integrator subunit 5 family.
Subcellular localisation
Nucleus
Target data
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com